论文部分内容阅读
目的:分析普米克令舒+可必特雾化吸入在毛细支气管炎治疗中的效果。方法:选择2011年3月至2012年12月在我院收治的120例毛细支气管炎患者,随着分为治疗组和对照组,对照组患者采用地塞米松+糜蛋白酶+0.9%氯化钠溶液进行雾化治疗,而治疗组则采用普米克令舒+可必特进行雾化治疗,对比两组患者临床治疗效果。结果:治疗组住院时间和病症缓解时间明显少于对照组;治疗组治疗总有效率为98.3%,而对照组的治疗总有效率为78.3%,治疗组治疗总有效率明显优于对照组,两组对比,差异明显,存在统计学意义(P<0.05)。结论:对毛细支气管炎患者采取普米克令舒联合可必特雾化吸入治疗,不仅能够快速环境患者临床病症,同时提高了治疗效果,帮助患者尽快恢复健康。
OBJECTIVE: To analyze the efficacy of pulmicort respules and nifibrate inhalation in the treatment of bronchiolitis. Methods: A total of 120 patients with bronchiolitis who were treated in our hospital from March 2011 to December 2012 were divided into treatment group and control group. Patients in the control group were treated with dexamethasone + chymotrypsin + 0.9% sodium chloride Solution for atomization treatment, while the treatment group is treated with Pulmicort Respules can be atomized treatment, compared the clinical efficacy of two groups of patients. Results: The hospitalization time and symptom relief time in the treatment group were significantly less than those in the control group. The total effective rate was 98.3% in the treatment group and 78.3% in the control group. The total effective rate in the treatment group was significantly better than that in the control group. There was significant difference between the two groups (P <0.05). CONCLUSIONS: Pulmicort respules combined with Kebil nebulized inhalation for patients with bronchiolitis not only provide rapid clinical response to environmental conditions, but also improve the therapeutic effect and help patients to recover as soon as possible.